Harmony Biosciences HRMY reported its Q2 earnings results on Tuesday, August 2, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Earnings
Harmony Biosciences beat estimated earnings by 29.55%, reporting an EPS of $0.57 versus an estimate of $0.44.
Revenue was up $33.21 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.22 which was followed by a 3.01% increase in the share price the next day.
Here's a look at Harmony Biosciences's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | 0.29 | 0.37 | 0.28 | 0.18 |
EPS Actual | 0.51 | 0.63 | 0.51 | 0.54 |
Revenue Estimate | 88.55M | 90.01M | 79.85M | 68.77M |
Revenue Actual | 85.31M | 91.21M | 80.73M | 73.82M |
To track all earnings releases for Harmony Biosciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.